This research introduces FXT-001, a novel pharmacological inhibitor designed to combat ferroptosis, a form of iron-dependent cell death that occurs during organ transplantation. The authors demonstrate that ischemia-reperfusion injury triggers a significant burst of lipid peroxidation in human and animal grafts, leading to severe tissue damage and organ dysfunction. Through preclinical testing in ...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动